TANG KEVIN purchased 7.9% of their position (900K shares) of AURINIA PHARMACEUTICALS INC. on the open market
Open‑market purchase worth $12.69M — a moderate purchase. The strongest form of insider conviction signal.
P · 6 purchases
Filed: 3/3/2026ACC: 0001178579-26-000001
+900K
Net shares
Net buyer
$12.69M
Total acquired
6
Open market trades
6B · 0S
6
Total transactions
900K acquired
Non-Derivative Transactions6
Common Shares
Indirect
Shares
+300K
Price / share
$13.90
Trade value
$4.17M
% of position
2.6%
2/27/2026
11.33M→11.63M
Common Shares
Indirect
Shares
+214.84K
Price / share
$14.12
Trade value
$3.03M
% of position
1.8%
2/27/2026
11.63M→11.84M
Common Shares
Indirect
Shares
+1.60K
Price / share
$14.38
Trade value
$23.01K
% of position
0.0%
2/27/2026
11.84M→11.85M
Common Shares
Indirect
Shares
+83.56K
Price / share
$14.33
Trade value
$1.20M
% of position
0.7%
3/2/2026
11.85M→11.93M
Common Shares
Indirect
Shares
+115.79K
Price / share
$14.21
Trade value
$1.65M
% of position
1.0%
3/2/2026
11.93M→12.05M
Common Shares
Indirect
Shares
+184.21K
Price / share
$14.22
Trade value
$2.62M
% of position
1.5%
3/3/2026
12.05M→12.23M
Total
Net shares
+900K
Net value
$12.69M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Shares Indirect | 2/27/2026 | P · Purchase | +300K | $13.90 | $4.17M | 2.6% | 11.33M | 11.63M |
| Common Shares Indirect | 2/27/2026 | P · Purchase | +214.84K | $14.12 | $3.03M | 1.8% | 11.63M | 11.84M |
| Common Shares Indirect | 2/27/2026 | P · Purchase | +1.60K | $14.38 | $23.01K | 0.0% | 11.84M | 11.85M |
| Common Shares Indirect | 3/2/2026 | P · Purchase | +83.56K | $14.33 | $1.20M | 0.7% | 11.85M | 11.93M |
| Common Shares Indirect | 3/2/2026 | P · Purchase | +115.79K | $14.21 | $1.65M | 1.0% | 11.93M | 12.05M |
| Common Shares Indirect | 3/3/2026 | P · Purchase | +184.21K | $14.22 | $2.62M | 1.5% | 12.05M | 12.23M |
| Total | +900K | $12.69M | ||||||
Derivative Transactions0
No derivative transactions reported